Table 1 |
||||
|
Pulmonary functions on etodolac and placebo treatments in patients with sinobronchial syndrome. |
||||
|
Run-in |
Placebo |
Wash out |
Etodolac |
|
|
|
||||
|
FVCs as % pred. (%) |
106.7 ± 4.3 |
108.8 ± 4.1 |
106.6 ± 4.4 |
112.5 ± 1.2 |
|
FEV1 s as % pred. (%) |
119.3 ± 5.1 |
118.8 ± 6.1 |
116.5 ± 9.1 |
112.0 ± 9.0 |
|
FEV1/FVC ratio as % pred. (%) |
76.6 ± 6.0 |
74.6 ± 7.0 |
76.3 ± 6.4 |
72.5 ± 5.4 |
|
|
||||
|
Data are shown as mean ± standard error of the mean for FVC, FEV1 and FEV1/FVC ratio. *p < 0.05 compared with each control value (Wilcoxon signed-ranks test). |
||||
|
Ishiura et al. Cough 2010 6:7 doi:10.1186/1745-9974-6-7 |
||||
